227 related articles for article (PubMed ID: 20055128)
41. An ultrafiltration high-performance liquid chromatography coupled with diode array detector and mass spectrometry approach for screening and characterising tyrosinase inhibitors from mulberry leaves.
Yang Z; Zhang Y; Sun L; Wang Y; Gao X; Cheng Y
Anal Chim Acta; 2012 Mar; 719():87-95. PubMed ID: 22340536
[TBL] [Abstract][Full Text] [Related]
42. Principles and applications of LC-MS in new drug discovery.
Korfmacher WA
Drug Discov Today; 2005 Oct; 10(20):1357-67. PubMed ID: 16253874
[TBL] [Abstract][Full Text] [Related]
43. Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.
Fauman EB; Rai BK; Huang ES
Curr Opin Chem Biol; 2011 Aug; 15(4):463-8. PubMed ID: 21704549
[TBL] [Abstract][Full Text] [Related]
44. Identification of inhibitors of the antibiotic-resistance target New Delhi metallo-β-lactamase 1 by both nanoelectrospray ionization mass spectrometry and ultrafiltration liquid chromatography/mass spectrometry approaches.
Chen X; Li L; Chen S; Xu Y; Xia Q; Guo Y; Liu X; Tang Y; Zhang T; Chen Y; Yang C; Shui W
Anal Chem; 2013 Aug; 85(16):7957-65. PubMed ID: 23863032
[TBL] [Abstract][Full Text] [Related]
45. Process technologies for purity enhancement of large discovery libraries.
Pottorf RS; Player MR
Curr Opin Drug Discov Devel; 2004 Nov; 7(6):777-83. PubMed ID: 15595438
[TBL] [Abstract][Full Text] [Related]
46. High-throughput solution-based medicinal library screening against human serum albumin.
Flarakos J; Morand KL; Vouros P
Anal Chem; 2005 Mar; 77(5):1345-53. PubMed ID: 15732917
[TBL] [Abstract][Full Text] [Related]
47. Identifying cellular targets of small-molecule probes and drugs with biochemical enrichment and SILAC.
Ong SE; Li X; Schenone M; Schreiber SL; Carr SA
Methods Mol Biol; 2012; 803():129-40. PubMed ID: 22065222
[TBL] [Abstract][Full Text] [Related]
48. HPLC-MS/MS in drug metabolism and pharmacokinetic screening.
Hsieh Y
Expert Opin Drug Metab Toxicol; 2008 Jan; 4(1):93-101. PubMed ID: 18370861
[TBL] [Abstract][Full Text] [Related]
49. High-throughput screening for enzyme inhibitors using frontal affinity chromatography with liquid chromatography and mass spectrometry.
Ng ES; Yang F; Kameyama A; Palcic MM; Hindsgaul O; Schriemer DC
Anal Chem; 2005 Oct; 77(19):6125-33. PubMed ID: 16194069
[TBL] [Abstract][Full Text] [Related]
50. Screening for topoisomerase I binding compounds by high-performance liquid chromatography-mass spectrometry.
Zhang H; Gu Q; Liang X; Pan Y
Anal Biochem; 2004 Jun; 329(2):173-9. PubMed ID: 15158475
[TBL] [Abstract][Full Text] [Related]
51. Automated approach for the rapid identification of purification conditions using a unified, walk-up high performance liquid chromatography/supercritical fluid chromatography/mass spectrometry screening system.
Aurigemma CM; Farrell WP; Simpkins J; Bayliss M; Alimuddin M; Wang W
J Chromatogr A; 2012 Mar; 1229():260-7. PubMed ID: 22321950
[TBL] [Abstract][Full Text] [Related]
52. Streamlined system for purifying and quantifying a diverse library of compounds and the effect of compound concentration measurements on the accurate interpretation of biological assay results.
Popa-Burke IG; Issakova O; Arroway JD; Bernasconi P; Chen M; Coudurier L; Galasinski S; Jadhav AP; Janzen WP; Lagasca D; Liu D; Lewis RS; Mohney RP; Sepetov N; Sparkman DA; Hodge CN
Anal Chem; 2004 Dec; 76(24):7278-87. PubMed ID: 15595870
[TBL] [Abstract][Full Text] [Related]
53. Screening for anti-proliferative and anti-inflammatory components from Rhamnus davurica Pall. using bio-affinity ultrafiltration with multiple drug targets.
Chen G; Wu J; Li N; Guo M
Anal Bioanal Chem; 2018 Jun; 410(15):3587-3595. PubMed ID: 29476234
[TBL] [Abstract][Full Text] [Related]
54. Immobilized artificial membrane chromatography with mass spectrometric detection: a rapid method for screening drug-membrane interactions.
Liu H; Carter GT; Tischler M
Rapid Commun Mass Spectrom; 2001; 15(17):1533-8. PubMed ID: 11544589
[TBL] [Abstract][Full Text] [Related]
55. High-performance liquid chromatography-mass spectrometry-based acetylcholinesterase assay for the screening of inhibitors in natural extracts.
de Jong CF; Derks RJ; Bruyneel B; Niessen W; Irth H
J Chromatogr A; 2006 Apr; 1112(1-2):303-10. PubMed ID: 16516896
[TBL] [Abstract][Full Text] [Related]
56. Concepts and technologies for tracking bioactive compounds in natural product extracts: generation of libraries, and hyphenation of analytical processes with bioassays.
Potterat O; Hamburger M
Nat Prod Rep; 2013 Apr; 30(4):546-64. PubMed ID: 23459784
[TBL] [Abstract][Full Text] [Related]
57. Screening drugs for metabolic stability using pulsed ultrafiltration mass spectrometry.
Geun Shin Y; Bolton JL; van Breemen RB
Comb Chem High Throughput Screen; 2002 Feb; 5(1):59-64. PubMed ID: 11860340
[TBL] [Abstract][Full Text] [Related]
58. Frontal affinity chromatography with MS detection (FAC-MS) in drug discovery.
Slon-Usakiewicz JJ; Ng W; Dai JR; Pasternak A; Redden PR
Drug Discov Today; 2005 Mar; 10(6):409-16. PubMed ID: 15808820
[TBL] [Abstract][Full Text] [Related]
59. Characterization of SH2-ligand interactions via library affinity selection with mass spectrometric detection.
Kelly MA; Liang H; Sytwu II; Vlattas I; Lyons NL; Bowen BR; Wennogle LP
Biochemistry; 1996 Sep; 35(36):11747-55. PubMed ID: 8794755
[TBL] [Abstract][Full Text] [Related]
60. Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods.
Houghten RA; Pinilla C; Giulianotti MA; Appel JR; Dooley CT; Nefzi A; Ostresh JM; Yu Y; Maggiora GM; Medina-Franco JL; Brunner D; Schneider J
J Comb Chem; 2008; 10(1):3-19. PubMed ID: 18067268
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
